Fig. 2 A-D.

(A) During postoperative Days 1 and 2, patients who were administered ketorolac consumed less oxycodone-acetaminophen than did those in the control group. Although patient-reported daily opioid consumption did not differ between the groups after Day 2, patients treated with ketorolac had (B) lower VAS pain scores (Days 1 to 3;), (C) better sleep (Days 1 to 4), and (D) lower frequency of pain (Days 1 to 3;) than patients in the control group. Asterisks indicate significant (p ≤ 0.05) differences between variables on that postoperative day.